Skip to the page

Data / Drug companies / Solution, concentrate

Companies that list solution, concentrate products: 35 companies and 69 products in the FDA NDC directory

The FDA National Drug Code Directory lists 69 products that are solution, concentrate products from 35 companies. The ten largest listers hold 52.2% of them, and the newest started marketing on April 15, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies
35
Products
69
Drugs by generic name
24
Main marketing category
Generic drugs (ANDA)

Companies that list solution, concentrate products

Ranked by number of products in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Aqua Medica, S.A. de C.V.9solution, concentrateOther unapproved drugsMarch 30, 2024
Amneal Pharmaceuticals Private Limited5solution, concentrateGeneric drugs (ANDA)July 9, 2025
Hikma Pharmaceuticals USA Inc.5solution, concentrateGeneric drugs (ANDA)October 31, 1993
Pilot Chemical Company4solution, concentrateDrugs for further processingMarch 29, 2023
Teva Pharmaceuticals, Inc.3solution, concentrateNew drug applications (NDA)June 1, 2022
Affordable Pharmaceuticals, LLC2solution, concentrateNew drug applications (NDA)August 5, 2010
Alexion Pharmaceuticals Inc.2solution, concentrateBiologics (BLA)October 9, 2020
Arxada, LLC2solution, concentrateDrugs for further processingDecember 6, 2022
Aurobindo Pharma Limited2solution, concentrateGeneric drugs (ANDA)January 31, 2017
Azurity Pharmaceuticals, Inc.2solution, concentrateNew drug applications (NDA)April 1, 2026
Bayer HealthCare Pharmaceuticals Inc.2solution, concentrateNew drug applications (NDA)December 6, 2022
Braintree Laboratories, Inc.2solution, concentrateNew drug applications (NDA)August 5, 2010
Institut National Des Radio-Elements2solution, concentrateDrugs for further processingJanuary 2, 2022
Organo Sintesis, S.A. de C.V.2solution, concentrateBulk ingredientsNovember 1, 2024
Sanofi-Aventis U.S. LLC2solution, concentrateBiologics (BLA)August 3, 2012
Somerset Therapeutics, LLC2solution, concentrateGeneric drugs (ANDA)October 23, 2025
Sucampo Pharma Limited Liability Company2solution, concentrateDrugs for further processingApril 1, 2010
Wilshire Pharmaceuticals, Inc.2solution, concentrateNew drug applications (NDA)April 15, 2026
Advagen Pharma Ltd1solution, concentrateGeneric drugs (ANDA)January 31, 2024
Endo USA, Inc.1solution, concentrateNew drug applications (NDA)October 1, 1998
Genentech, Inc.1solution, concentrateBiologics (BLA)June 15, 2023
Hikma Pharmaceuticals USA Inc.1solution, concentrateGeneric drugs (ANDA)April 23, 2019
Micro Labs Limited1solution, concentrateGeneric drugs (ANDA)May 4, 2013
Miyoshi America, Inc.1solution, concentrateDrugs for further processingApril 4, 2016
Mylan Pharmaceuticals Inc.1solution, concentrateGeneric drugs (ANDA)August 28, 2009
Mylan Pharmaceuticals Inc.1solution, concentrateAuthorized generics (NDA)May 15, 2018
Omnivium Pharmaceuticals LLC.1solution, concentrateGeneric drugs (ANDA)August 31, 2024
Pai Holdings, LLC DBA Pai Pharma1solution, concentrateGeneric drugs (ANDA)September 1, 2010
Patheon Biologics B.V.1solution, concentrateDrugs for further processingFebruary 8, 2020
Polpharma Biologics SA1solution, concentrateBulk ingredientsJune 9, 2022
Rising Pharma Holdings, Inc.1solution, concentrateGeneric drugs (ANDA)October 31, 2008
Rising Pharma Holdings, Inc.1solution, concentrateGeneric drugs (ANDA)December 5, 2011
Sportpharm LLC1solution, concentrateGeneric drugs (ANDA)September 1, 1983
Takeda Pharmaceuticals America, Inc.1solution, concentrateBiologics (BLA)July 24, 2006
Viatris Specialty LLC1solution, concentrateNew drug applications (NDA)November 21, 2024

Drugs most often listed

DrugProducts hereCompanies listing it
Sertraline hydrochloride455
Lorazepam138
Alprazolam137
Haloperidol132
Fluphenazine hydrochloride129
Cromolyn sodium311
Pemetrexed39
Sodium sulfate, potassium sulfate, magnesium sulfate86
Levalbuterol25
Dexamethasone intensol22
Larotrectinib22
Acid concentrate for hemodialysis41
Hemodialysis grade sodium bicarbonate solution31
Ravulizumab21
Sodium acetate anhydrous21
Ziv-aflibercept21
Cleaning solution for hemodialysis machines11
Desinfectant solution for hemodialysis machine11
Diazepam intensol11
Glofitamab11
Idursulfase11
Prednisone intensol11
Valrubicin11
Valrubicin intravesical solution11

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.